| 1 |
34599040 | Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone-Inhibitory Effect of Octreotide after Growth Hormone-Releasing Hormone Stimulation. | 2021 Dec |
1 |
| 2 |
20379782 | Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy. | 2012 Jun |
2 |
| 3 |
22539587 | Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppression. | 2012 Jul |
1 |
| 4 |
19017754 | Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies. | 2009 Feb |
4 |
| 5 |
17373589 | Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment. | 2007 |
1 |
| 6 |
17541749 | Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients. | 2007 |
1 |
| 7 |
15356066 | Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men. | 2004 Sep |
2 |
| 8 |
11155087 | No advantage of the new combined octreotide-GHRH test over established GH-stimulation tests in the diagnosis of growth hormone deficiency (GHD) in adults. | 2000 Dec |
2 |
| 9 |
8675565 | Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency. | 1996 Jul |
1 |
| 10 |
8740200 | The attenuated inhibitory action of octreotide, a somatostatin analogue on GHRH-induced growth hormone response in type I diabetes mellitus. | 1996 Apr |
1 |
| 11 |
7581949 | Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion. | 1995 Sep |
2 |
| 12 |
7962343 | Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and alpha-subunit-secreting tumors from acromegalic patients responsive to octreotide. | 1994 Nov |
3 |
| 13 |
8187302 | Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects. | 1994 Mar |
6 |
| 14 |
1518441 | Potential indications for octreotide in endocrinology. | 1992 Sep |
2 |
| 15 |
1521513 | Ectopic acromegaly. | 1992 Sep |
2 |
| 16 |
1839344 | Progestins and growth hormone excess in the dog. | 1991 |
1 |
| 17 |
2493033 | Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion. | 1989 Feb |
6 |
| 18 |
2506217 | The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man. | 1989 Oct |
2 |
| 19 |
2899089 | Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor. | 1988 Aug |
2 |